Obiettivo
2D-BioPAD is a cost-effective, non-invasive point of care/self-testing tool for the early and accurate prognosis (assistive diagnosis) of Alzheimer's Disease, with special focus on earlier stages such as Subjective or Mild Cognitive Impairment (SCI/MCI).
Campo scientifico
Parole chiave
Programma(i)
Argomento(i)
Invito a presentare proposte
HORIZON-CL4-2022-DIGITAL-EMERGING-02
Vedi altri progetti per questo bandoMeccanismo di finanziamento
HORIZON-RIA - HORIZON Research and Innovation ActionsCoordinatore
771 47 Olomouc
Cechia